Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin-Free ECMO Support in Lung Transplantation
NCT05697692Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Start
- Dec 2022
- Primary completion
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in thrombosis, sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
heparin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT05697692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05697692.